Date

Tuesday, March 21, 2023

Venue

Time

10:00 (GMT+7)

Agenda

AGMS

1. Approval and ratification of the Annual Report including the Board of Commissioners Supervisory Report, Directors Task Report; and ratification of the company's Consolidated Financial Statements 2022;
2. Determination on the use of the company's Net Profit of the financial year 2022;
3.  Appointment of a Public Accounting Firm (KAP) to audit the company's Financial Statements of the financial year 2023;
4. Delegation of authority to Board of Commissioners to determine the salary/honorarium and/or other benefits for Board members.

EGMS

1. Approval for the implementation of increasing the company's capital with Pre-emptive Rights to shareholders ("PMHMETD"), in accordance with OJK Regulation No.14/POJK.04/2019 regarding amendments to OJK Regulation No.32/POJK.04/2015 regarding Capital Increases for Public Companies with Pre-emptive Rights and OJK Regulation No.32/POJK.04/2015 regarding the capital increases for Public Companies with Pre-emptive Rights, including Approval for the Warrants issuance or the issuance of other accompanying equity securities. issuance of Preemptive Rights; and approval of amendments to the company's Articles of Association in relation to Preemptive Rights, including but not limited to change the company's capital structure; and approval to authorise Board of Directors with the rights of substitution to take all necessary actions in order to issue Preemptive Rights;
2. Approval to borrow a number of funds from financial institutions, banks and/or non-financial institutions and guarantee most of the company's assets and/or grant the company's Corporate Guarantee to other financial institutions, banks and/or non-financial institutions.